UK Veterinary Healthcare Market Size & Forecast | 2031
UK Veterinary Healthcare Market Size & Forecast | 2031
Segments - United Kingdom Veterinary Healthcare Market by Products (Therapeutics [Vaccines, Anti-infectives, Medical Feed Additives, Parasiticides, and Others]and Diagnostics [Molecular Diagnostics, Diagnostic Imaging, Immunodiagnostic Tests, Clinical Chemistry, and Other]), Animal Types (Dogs & Cats, Horses, Ruminants, Swine, Poultry, and Other), and Country (United Kingdom) - United Kingdom Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-3698
| 4.9 Rating
| 57 Reviews
| 202 Pages
| Format :
Report Description
The United Kingdom veterinary healthcare market size was USD 1.53 Billion in 2022 and is likely to reach USD 2.80 Billion by 2031, expanding at a CAGR of 6.94% during 2023–2031. The growth of the market is attributed to growing technical developments and public knowledge of zoonotic and foodborne illnesses.
The number of veterinarians employed in the United Kingdom was estimated to be at 27.2 thousand in 2021. As a result of the rising number of veterinarians working in the UK, the number of businesses engaged in veterinary operations has expanded as well. There are 4,058 veterinary businesses in the United Kingdom as of 2018.
The Royal College of Veterinary Surgeons (RCVS) controls veterinary medicine in the United Kingdom. Veterinary medicine may only be practiced by fully certified and licensed practitioners, according to the Veterinary Surgeons Act of 1966.
Pets are a significant part of family life in the United Kingdom, with families spending over five billion British pounds on veterinarian and other pet services in 2018. In 2018, UK families spent an average of 2.5 British pounds per week on pet food and 2.1 British pounds per week on veterinarian and other pet services.
According to the Pet Food Manufacturers' Association (PFMA), which recently released its yearly pet population numbers for 2021, 3.2 million homes in the United Kingdom have adopted a pet since the epidemic began. Two-thirds (59%) of new pet owners are between the ages of 16 and 34, and 56% of new pet owners have children at home, owing to the influence of Gen Z and Millennials. Despite the fact that 74 percent of respondents said their pet has helped them cope with the epidemic, the survey raises concerns about animal care.
UK has a implemented the Animal Welfare Act 2006 imposes a legal duty of care on their owners or keepers to provide for their animals' welfare needs, which include the five welfare needs of health, diet, environment, behavior, and companionship.
Rising instances of animal diseases on 3rd November 2021, the virus that causes Covid-19 has been found in a domestic dog in the United Kingdom, according to the country's Chief Veterinary Officer examinations at the Animal and Plant Health Agency (APHA) laboratory in Weybridge confirmed the illness. The dog is now being cared after at home.
The UK Health Security Agency (UKHSA) announced a positive Brucella Canis blood test result in a dog in June 2020. Brucella Canis is a parasite that affects both dogs and humans. It can induce reproductive failure in dogs and fever, peripheral lymph adenomegaly, chills, malaise, and splenomegaly in humans.
United Kingdom Veterinary Healthcare Market Trends, Drivers, Restraints, and Opportunities
-
Increasing pet owners’ conscious for pet health’s is projected to boost the market during the forecast period.
-
Rising pet adoption is anticipated to drive the market expansion in the coming years.
-
Growing demand for animal-based products are expected to propel the market.
-
Increasing animal adoption and animal care centers in the country are estimated to spur the market.
-
Rapid growth of the healthcare industry is main factors boosting the market growth in the coming years.
-
Rising number of diseases in animals is projected to surge the product demand.
-
Increasing risk of disease spread by animal’s act as a major challenge to hinder the market growth.
-
Development innovation and sophisticated technology for treatment and diagnosis are expected to create significant opportunities for the market players.
Scope of United Kingdom Veterinary Healthcare Market Report
The report on the United Kingdom veterinary healthcare market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Veterinary Healthcare Market - United Kingdom Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Products (Therapeutics [Vaccines, Anti-infectives, Medical Feed Additives, Parasiticides, and Others]and Diagnostics [Molecular Diagnostics, Diagnostic Imaging, Immunodiagnostic Tests, Clinical Chemistry, and Other), Animal Types (Dogs & Cats, Horses, Ruminants, Swine, Poultry, and Other) |
|
Country Scope |
United Kingdom |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Virbac Corporation; Ceva Santé Animale; Bayer AG; Boehringer Ingelheim; MSD Animal Health |
United Kingdom Veterinary Healthcare Market Segment Insights
Based on products, the United Kingdom veterinary healthcare market is divided into therapeutics and diagnostics. The diagnostics segment is further segmented to molecular diagnostics, diagnostic imaging, immunodiagnostic tests, clinical chemistry, and other. The molecular diagnostics expected to represent a key share of the market during the forecast period owing to faster and sensitivity techniques used to identify the disease in animal at genomic level.
On the Animal types, the United Kingdom veterinary healthcare market is segmented into dogs & cats, horses, ruminants, swine, poultry, and other. The dog segment is expected to hold a key share of the market in the coming years owing to commonly adopted pet in the region. According to APPA national pet owners survey approx. 75% of households owns a dog pet.
Segments
The United Kingdom veterinary healthcare market has been segmented on the basis of
Products
- Therapeutics
- Vaccines
- Anti-infectives
- Medical Feed Additives
- Parasiticides
- Others
- Diagnostics
- Molecular Diagnostics
- Diagnostic Imaging
- Immunodiagnostic Tests
- Clinical Chemistry
- Other
Animal Types
- Dog & Cat
- Horses
- Ruminants
- Swine
- Poultry
- Others
Country
- United Kingdom
Key Market Players
- Virbac Corporation
- Ceva Santé Animale
- Bayer AG
- Boehringer Ingelheim
- MSD Animal Health
Competitive Landscape
Key players competing in the United Kingdom veterinary healthcare market include Virbac Corporation; Ceva Santé Animale; Bayer AG; Boehringer Ingelheim; MSD Animal Health. Some of these players are coming up with several market strategies including mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase/enhance their market shares. For instance,
- In July 2020, Belgian biotech company, GST, acquired by Boehringer Ingelheim to boost its stem cell capabilities in animal health.
- In January 2020, to significantly accelerate the delivery of its veterinary healthcare system, IDEXX announced a quick digital cytology service.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Veterinary Healthcare Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Veterinary Healthcare Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Veterinary Healthcare Market - Supply Chain
4.5. Global Veterinary Healthcare Market Forecast
4.5.1. Veterinary Healthcare Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Veterinary Healthcare Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Veterinary Healthcare Market Absolute $ Opportunity
5. Global Veterinary Healthcare Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Veterinary Healthcare Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Veterinary Healthcare Demand Share Forecast, 2019-2026
6. North America Veterinary Healthcare Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Veterinary Healthcare Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Veterinary Healthcare Demand Share Forecast, 2019-2026
7. Latin America Veterinary Healthcare Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Veterinary Healthcare Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Veterinary Healthcare Demand Share Forecast, 2019-2026
8. Europe Veterinary Healthcare Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Veterinary Healthcare Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Veterinary Healthcare Demand Share Forecast, 2019-2026
9. Asia Pacific Veterinary Healthcare Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Veterinary Healthcare Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Veterinary Healthcare Demand Share Forecast, 2019-2026
10. Middle East & Africa Veterinary Healthcare Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Veterinary Healthcare Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Veterinary Healthcare Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Veterinary Healthcare Market: Market Share Analysis
11.2. Veterinary Healthcare Distributors and Customers
11.3. Veterinary Healthcare Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. Virbac Corporation
11.4.2. Ceva Santé Animale
11.4.3. Bayer AG
11.4.4. Boehringer Ingelheim
11.4.5. MSD Animal Health
Methodology
Related Reports
Some other reports from this category!
Our Clients
